Below is a list of Ceiba’s ongoing research projects and questionnaires regarding iboga and ibogaine.
Your participation is greatly appreciated!
Ibogaine Experience Scale (IES)
A questionnaire being developed in partnership with ICEERS to assess the acute subjective effects of ibogaine. Please complete within 48-hours after the acute effects subside.
Approximately: 20 minutes to complete
If you have taken ibogaine in the last 48-hours, click here to participate.
Exploring the Oneirogenic Experience in Ibogaine Therapy
This is a mixed-method observational study that seeks to explore the nature of the oneirogenic experience stimulated by ibogaine, and to make an exploratory assessment of some factors that influence this experience.
Approximately: 6-8 hours total, over a 6 week period
If you a US resident and are planning to attend ibogaine treatment soon, click here for info.
Articles & Publications
Krengel, F., Dickinson, J., Jenks, C., Reyes-Chilpa, R. (2020). Quantitative Evaluation of a Mexican and a Ghanaian Tabernaemontana Species as Alternatives to Voacanga africana for the Production of Antiaddictive Ibogan Type Alkaloids. Chemistry and Biodiversity. https://doi.org/10.1002/cbdv.202000002
Krengel, F., Chevalier, Q., Dickinson, J., Herrera-Santoyo, J., Olivera-Flores, T., Reyes-Chilpa, R. (2019). Metabolite Profiling of Antiaddictive Alkaloids from Four Mexican Tabernaemontana Species and the Entheogenic African Shrub Tabernanthe iboga (Apocynaceae). Chemistry and Biodiversity, 16(4):e18005. https://doi.org/10.1002/cbdv.201800506
Dickinson, J. (2016). Iboga Root: Dynamics of Iboga’s African Origins and Modern Medical Use. HerbalGram: The Journal of the American Botanical Council. Retrieved from https://www.herbalgram.org/resources/herbalgram/issues/109/table-of-contents/hg109-feat-iboga/
Dickinson, J., McAlpin, J., Wilkins, C., Fitzsimmons, C., Paterson, T., Greene, D., Chaves, B.R. (2015). Clinical Guidelines for Ibogaine-Assisted Detoxification. The Global Ibogaine Therapy Alliance. Retrieved from https://www.ibogaineguidelines.com